Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.

Pediatric pulmonology - 1 Jun 2007

Nguyen Dao, Emond Mary J, Mayer-Hamblett Nicole, Saiman Lisa, Marshall Bruce C, Burns Jane L

Abstract excerpt

A 6-month clinical trial of azithromycin (AZM) in American cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa infection showed clinical improvement without significant reduction in bacterial density. Sub-inhibitory AZM has been hypothesized to affect P. aeruginosa virulence, partly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azithromycin
Share to Cystic Fibrosis
Share to Forced Expiratory Volume

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Linear Models

Share to Pseudomonas aeruginosa

Share to Pseudomonas Infections

Share to Respiratory System

Share to Type C Phospholipases

Source

Identifiers

PMID: 17469154
DOI: 10.1002/ppul.20620

Genes

FEV

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17469154-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.PMID 17469154Read ↗

Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.Semantic proximity Read ↗

Pseudomonas aeruginosa Phenotypes Associated with Radiological Severity in Non-Cystic Fibrosis BronchiectasisSemantic proximity Read ↗

Pseudomonas aeruginosa phenotypes associated with radiological severity in non-cystic fibrosis bronchiectasis.Semantic proximity Read ↗

Effects of Antibiotics on Quorum Sensing in <i>Pseudomonas aeruginosa</i>Semantic proximity Read ↗

Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.Semantic proximity Read ↗

Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.Semantic proximity Read ↗

Chronic infection phenotypes of Pseudomonas aeruginosa are associated with failure of eradication in children with cystic fibrosis.Semantic proximity Read ↗

Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.Semantic proximity Read ↗

Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa.Semantic proximity Read ↗

Swimming motility in a longitudinal collection of clinical isolates of Burkholderia cepacia complex bacteria from people with cystic fibrosis.Semantic proximity Read ↗

Ribosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa.Semantic proximity Read ↗

Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.